Moderna says Health Canada has approved its mRNA vaccine, shown in a handout photo, to protect against respiratory syncytial virus in adults age 60 and older. THE CANADIAN PRESS/HO-Moderna **MANDATORY CREDIT**
In a news release, Moderna said it expects the RSV vaccine — called mRESVIA — to be available in early 2025. Earlier this year, the National Advisory Committee on Immunization recommended RSV immunization for adults 75 years and older. According to the Public Health Agency of Canada's wastewater surveillance, the level of RSV circulating is currently"moderate" across much of the country.
Hemos resumido esta noticia para que puedas leerla rápidamente. Si estás interesado en la noticia, puedes leer el texto completo aquí. Leer más:
España Últimas Noticias, España Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
Health Canada approves Moderna's mRNA RSV vaccine, company saysTORONTO — Moderna says Health Canada has approved its mRNA vaccine to protect against respiratory syncytial virus in adults age 60 and older. The company says it expects the RSV vaccine — called mRESVIA — to be available in early 2025.
Fuente: SooToday - 🏆 8. / 85 Leer más »
Health Canada approves Moderna's mRNA RSV vaccine, company saysTORONTO — Moderna says Health Canada has approved its mRNA vaccine to protect against respiratory syncytial virus in adults age 60 and older. The company says it expects the RSV vaccine — called mRESVIA — to be available in early 2025.
Fuente: BurnabyNOW_News - 🏆 14. / 77 Leer más »
Health Canada approves Moderna's mRNA RSV vaccine, company saysTORONTO — Moderna says Health Canada has approved its mRNA vaccine to protect against respiratory syncytial virus in adults age 60 and older. The company says it expects the RSV vaccine — called mRESVIA — to be available in early 2025.
Fuente: PGCitizen - 🏆 65. / 51 Leer más »
Health Canada approves Moderna’s mRNA RSV vaccine, company saysHealth Canada has approved Moderna's mRNA vaccine to protect against respiratory syncytial virus in adults age 60 and older.
Fuente: CHEK_News - 🏆 59. / 55 Leer más »
Health Canada approves Moderna's mRNA RSV vaccine, company saysHealth Canada has approved Moderna's mRNA vaccine to protect against respiratory syncytial virus in adults age 60 and older, available next year.
Fuente: CTVNews - 🏆 1. / 99 Leer más »
Health Canada approves Moderna’s mRNA RSV vaccine, company saysAgency approves the vaccine to protect against respiratory syncytial virus in adults age 60 and older
Fuente: globeandmail - 🏆 5. / 92 Leer más »